Press Room
August 2021
NKF and NephCure Kidney International Invited Patients to Speak About Membranous Nephropathy
August 31, 2021, New York, NY— The National Kidney Foundation (NKF) in partnership with the NephCure Kidney International, Inc. (NephCure) hosted a gathering of patients and care...
August 2021
Update: Reassessing Inclusion of Race in Diagnosing Kidney Diseases
A joint statement from the National Kidney Foundation and the American Society of Nephrology
August 24, 2021 - The National Kidney Foundation (NKF) and the American Society of...
August 2021
NKF Applauds FDA Action on Third Dose of COVID-19 Vaccine
August 13, 2021, New York, NY— The National Kidney Foundation (NKF) applauds the Food and Drug Administration (FDA) for amending the emergency use authorizations for the Pfizer and the...
August 2021
NKF Partners with Alport Syndrome Foundation to expand Kidney Disease Patient Registry
August 9, 2021 — A new partnership between the National Kidney Foundation (NKF) and the Alport Syndrome Foundation (ASF) is designed to give hope to the thousands of...
August 2021
National Kidney Foundation and Labcorp Data Show Millions Aren’t Tested for Kidney Disease
Authors studied lab results for 28 million Americans with the highest risk and found most are not getting recommended tests to detect life-threatening disease
August 5, 2021, New York, NY —...
August 2021
NKF and ASN Statement on Patient Access to New Drug Treatment Options
August 3, 2021
As new therapeutic drug treatments become available to help slow the progression of kidney disease, it is important to ensure that patients have access to, and can afford,...